“This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). This fatal condition does not have a known cause and research investigating its pathology is ongoing.” Learn more about Idiopathic Pulmonary Fibrosis: https://bit.ly/1QiRmr3…
Idiopathic Pulmonary Fibrosis: The Simple Facts
Researchers discovered that mechanotherapy on damaged muscle tissue reduces both fibrotic tissue accumulation and inflammation while helping to increase tissue regeneration, according to a new study titled “Biologic-free mechanically induced muscle regeneration,” published in the journal Proceedings of the National Academy of Sciences (PNAS). Although focusing on the repair…
https://www.youtube.com/watch?v=98vpzgy94kk Learn more about IPF: https://bit.ly/1QiRmr3…
Watch the president and CEO of the Pulmonary Fibrosis Foundation, Dr. Daniel M. Rose, talk about the disease. Learn more about IPF: https://bit.ly/1QiRmr3…
Spherix Global Insights, GmbH, a business intelligence and market research company based in Switzerland, recently reported a study revealing that idiopathic pulmonary fibrosis (IPF) remains a challenge in terms of treatment, especially since the majority of patients are diagnosed at already advanced disease stages. The Spherix…
UT Health Northeast, a medical center that is part of the University of Texas system, recently announced in a press release that four of its scientists have received a total of $2.1 million in competitive research grants. The researchers are Dr. Vijay Rao, Dr. Krishna Vankayalapati, Dr. Hong-Long Ji,…
“Ever wanted to know what NOT to say to someone living with a chronic illness? Well here is your 101 on things you probably shouldn’t say.” Learn more about pulmonary fibrosis: https://bit.ly/1lfMsiZ…
Learn more about IPF: https://bit.ly/1QiRmr3…
Last week’s hot topic on pulmonary fibrosis was NY Times Covers Story of IPF Patient’s Progress with Esbriet Treatment written by Isaura Santos. This article follows a story covered by the NY Times, about an IPF patient’s…
A European survey of patients with idiopathic pulmonary fibrosis (IPF) found that patients well understand the disease’s significant physical and emotional impact on their quality of life, and are frustrated by a perceived lack of quality IPF information and public understanding. The study also underscored the beneficial role of patients’ caregivers and specialist nurses, where available.
